Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 17, Pages 4280
Publisher
MDPI AG
Online
2022-09-02
DOI
10.3390/cancers14174280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes
- (2022) Nikolaos Zacharakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Hallmarks of Cancer: New Dimensions
- (2022) Douglas Hanahan Cancer Discovery
- PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
- (2022) Qin Wu et al. Nature Chemical Biology
- H3K27me3 conditions chemotolerance in triple-negative breast cancer
- (2022) Justine Marsolier et al. NATURE GENETICS
- Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer
- (2021) Allison P. Drain et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Triple-negative breast cancer: understanding Wnt signaling in drug resistance
- (2021) Parnaz Merikhian et al. Cancer Cell International
- Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer
- (2021) Hisako Ono et al. CANCER SCIENCE
- An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
- (2021) Hina Qayoom et al. Future Oncology
- A persistent look at how tumours evade therapy
- (2021) Karen Gomez et al. NATURE
- Cancer stem cells in TNBC
- (2021) Zhan Hua et al. SEMINARS IN CANCER BIOLOGY
- Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
- (2021) Katsutoshi Sato et al. Nature Communications
- Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
- (2021) Anindita Chakrabarty et al. Frontiers in Oncology
- Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer
- (2021) Willy Antoni Abreu de Oliveira et al. Frontiers in Oncology
- Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape
- (2021) Giulia Salvadori et al. Cell Metabolism
- JAK2 regulates paclitaxel resistance in triple negative breast cancers
- (2021) Jongmin Han et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
- (2021) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
- (2021) Brian D. Lehmann et al. Nature Communications
- Immunomodulating Therapies in Breast Cancer—From Prognosis to Clinical Practice
- (2021) Marcus Schmidt et al. Cancers
- Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
- (2021) Andrew Sulaiman et al. Biomedicines
- Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
- (2020) Guoxuan Gao et al. BMC CANCER
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Fibrosis and cancer: A strained relationship
- (2020) Bram Piersma et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Metabolic Reprogramming in Triple-Negative Breast Cancer
- (2020) Xiangyu Sun et al. Frontiers in Oncology
- Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases
- (2020) Lin-Yu Xia et al. World Journal of Surgical Oncology
- Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of Rarβ
- (2020) Gabriela Paroni et al. Cancers
- Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
- (2019) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Stem cells: past, present, and future
- (2019) Wojciech Zakrzewski et al. Stem Cell Research & Therapy
- Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
- (2019) Yi-Zhou Jiang et al. CANCER CELL
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
- (2019) Maria Laura De Angelis et al. Frontiers in Oncology
- Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications
- (2019) Jiaojiao Zhou et al. Frontiers in Oncology
- Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
- (2019) De Angelis et al. Cancers
- TBCRC 032 IB/II Multicenter Study: Molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer
- (2019) Brian D. Lehmann et al. CLINICAL CANCER RESEARCH
- Molecular stratification within triple-negative breast cancer subtypes
- (2019) Dong-Yu Wang et al. Scientific Reports
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- Senescence Elicits Stemness: A Surprising Mechanism for Cancer Relapse
- (2018) Zhixun Dou et al. Cell Metabolism
- Triple-Negative Breast Cancer
- (2018) Lubna N. Chaudhary et al. Surgical Oncology Clinics of North America
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- Dramatic dysbalancing of the Wnt pathway in breast cancers
- (2018) Alexey Koval et al. Scientific Reports
- Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
- (2018) Mihriban Karaayvaz et al. Nature Communications
- Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer
- (2018) François M. Vallette et al. BIOCHEMICAL PHARMACOLOGY
- Targeting the Hippo Pathway for Breast Cancer Therapy
- (2018) Liqing Wu et al. Cancers
- CD44+/CD24‑ phenotype predicts a poor prognosis in triple‑negative breast cancer
- (2017) Hui Wang et al. Oncology Letters
- Cancer therapy: Defining stemness
- (2016) Hans Clevers NATURE
- Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
- (2016) Michael Ramirez et al. Nature Communications
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Overexpression of sonic hedgehog in the triple negative breast cancer: clinicopathological characteristics of high burden breast cancer patients from Bangladesh
- (2016) A. S. Noman et al. Scientific Reports
- PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a -Secretase Inhibitor
- (2015) K. Wang et al. CLINICAL CANCER RESEARCH
- Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
- (2015) Tari A. King et al. Nature Reviews Clinical Oncology
- Enriched CD44+/CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
- (2014) Fei Ma et al. CANCER LETTERS
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases
- (2014) Ying Liu et al. MEDICAL ONCOLOGY
- Stem cell characteristics of dormant cells and cisplatin-induced effects on the stemness of epithelial ovarian cancer cells
- (2014) NAN ZHOU et al. Molecular Medicine Reports
- Expression of cancer stem cell markers in basal and penta-negative breast carcinomas – A study of a series of triple-negative tumors
- (2014) Diego de Mendonça Uchôa et al. PATHOLOGY RESEARCH AND PRACTICE
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- Mechanisms of Metastatic Tumor Dormancy
- (2013) Mary Osisami et al. Journal of Clinical Medicine
- In Situ Identification of CD44+/CD24− Cancer Cells in Primary Human Breast Carcinomas
- (2012) Giuseppe Perrone et al. PLoS One
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation
- (2010) J. A. Bauer et al. CLINICAL CANCER RESEARCH
- Src signaling in cancer invasion
- (2010) Marcello Guarino JOURNAL OF CELLULAR PHYSIOLOGY
- Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials
- (2010) Nicolai Juul et al. LANCET ONCOLOGY
- Genomic instability in breast cancer: Pathogenesis and clinical implications
- (2010) Kevin A. Kwei et al. Molecular Oncology
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
- (2009) B. T. Hennessy et al. CANCER RESEARCH
- Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma
- (2009) Jennifer L. Dembinski et al. CLINICAL & EXPERIMENTAL METASTASIS
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
- (2009) Elgene Lim et al. NATURE MEDICINE
- Phenotypic and Functional Characterization of Human Mammary Stem/Progenitor Cells in Long Term Culture
- (2009) Devaveena Dey et al. PLoS One
- Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast
- (2008) M. J. Hayes et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started